开窗医生改良腔内移植物治疗迷走右锁骨下动脉和/或Kommerell憩室
回顾性分析2018至2022年6例迷走右锁骨下动脉和/或Kommerell憩室患者行杂交主动脉弓修复联合自制开窗支架,平均年龄49岁,平均随访16个月,技术成功率100%,30天死亡率0%,无卒中及内漏,随访期间无主动脉相关死亡或二次干预,主动脉上血管均通畅。
要点
- 开窗医生改良腔内移植物用于迷走右锁骨下动脉和/或Kommerell憩室杂交弓部修复技术成功率100%。
- 30天死亡率0%,无卒中及内漏,随访期间无主动脉相关死亡或二次干预。
- 随访期间所有主动脉上血管保持通畅。
核心结论
- 采用开窗医生改良腔内移植物治疗迷走右锁骨下动脉和/或Kommerell憩室的杂交主动脉弓修复,其早期和中期的重大并发症发生率和死亡率可接受。
- 作者认为,开窗医生改良腔内移植物用于迷走右锁骨下动脉患者的管理,在中期的安全、有效且持久。
研究设计与样本
- 回顾性病例系列,纳入2018至2022年所有连续接受杂交主动脉弓修复联合自制开窗支架的迷走右锁骨下动脉和/或Kommerell憩室患者。
- 共6例患者,其中4例为男性,平均年龄49岁。
主要发现
- 6例患者中2例有吞咽困难症状,1例急诊入院,1例有牛型主动脉弓和Kommerell憩室,2例为右位降主动脉。
- 平均手术时间138(111-216)分钟,83%的自制移植物为双开窗。
- 所有近端锚定区均在0区,平均近端主动脉直径29(23-34)mm,移植物直径范围24至38 mm。
- 技术成功率100%,30天死亡率0%,无卒中,无内漏。
- 随访期间无主动脉相关死亡或二次干预,所有主动脉上血管保持通畅。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this case series is to report feasibility, efficiency, and safety of fenestrated physician-modified endografts (PMEGs) in aortic arch pathologies with aberrant right subclavian artery (ARSA) and/or Kommerell's diverticulum (KD). METHODS: All consecutive patients with ARSA and/or KD who underwent hybrid aortic arch repair combined with homemade fenestrated stent-graft from 2018 to 2022 were reviewed. RESULTS: Six patients with ARSA and/or KD underwent hybrid surgery for aortic repair, 4 of whom were men, with a mean age of 49 years. Furthermore, 2 of them were symptomatic with dysphagia, 1 was taken in emergency, 1 had a bovine arch and a KD, and 2 had right descending thoracic aortas. The mean operation time was 138 (111-216) minutes. In addition, 83% of the homemade grafts were double fenestrated. All the proximal landings were in zone 0; the mean proximal aortic diameter was 29 (23-34) mm. The range of diameters for the endografts were 24 to 38 mm. There was a 100% technical success, with 0% 30 days mortality, no stroke, and no endoleak. During the follow-up, no aortic-related death or secondary intervention was required and all supra-aortic vessels remain patent. CONCLUSION: Hybrid aortic arch repair, with fenestrated PMEGs for ARSA and/or KD, is associated with acceptable early and midterm major morbidity and mortality.Clinical ImpactThis retrospective case series analyzed outcomes in 6 patients with an aberrant right subclavian artery and/or Kommerell's diverticulum treated with fenestrated PMEGs during an average 16 month follow-up. The case series suggests that the use of these fenestrated PMEGs for the management of patients with an aberrant right subclavian artery is a safe, effective and durable method in the medium-term.
引用
- Bacri C, Chastant R, Chassin-Trubert L, et al. Fenestrated Physician-Modified Endovascular Grafts for Aberrant Right Subclavian Artery and/or Kommerell's diverticulum. J Endovasc Ther. 2023. PMID: 37752861. doi:10.1177/15266028231202234
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。